Different pro- and anti-inflammatory interleukins (ILs) from the IL 1 family were correlated with the development of T2DM from PD (e.g., IL-18 [14] and interleukin 1 receptor antagonist (IL-1RA) protein [15]). This evidence concerns the gene IL1RN and type 2 diabetes mellitus.